Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)
for
Thrombocytopenia, Neonatal Alloimmune
Location: Philadelphia PA, Rochester NY, Chapel Hill NC,
Sponsor: Janssen Research & Development, LLC
Sex: Female
Age: 18 - 45
Code: NCT06533098
Phase 3, Recruiting
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
for
Atrial Fibrillation (AF)
Location: Valhalla NY, Philadelphia PA, Jacksonville FL, Tampa FL,
Sponsor: Vektor Medical
Sex: All
Age: 22+
Code: NCT06935591
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: Shirley NY, New Haven CT, Mineola NY, The Bronx NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase 3, Recruiting
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
for
Type 1 Diabetes Mellitus
Location: Halifax, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Sanofi
Sex: All
Age: 1 - 25
Code: NCT07088068
Phase 3, Recruiting
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
Get alerts for new trials in your area by subscribing now
A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety
for
Epileptic Encephalopathy, SCN2A Encephalopathy
Location: Philadelphia PA, Cincinnati OH, Chicago IL, Memphis TN,
Sponsor: Praxis Precision Medicines
Sex: All
Age: 0 - 18
Code: NCT07019922
Phase 3, Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
for
Ulcerative Colitis, Obesity or Overweight
Location: London, New Bedford MA, Providence RI, Lebanon NH,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937086
Phase 3, Recruiting
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
for
Crohn's Disease, Obesity or Overweight
Location: London, New Bedford MA, Providence RI, Lebanon NH,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70
Code: NCT06937099
Phase 3, Recruiting
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
A Study to Assess Adverse Events and Change in Disease Activity in Participants With Platinum-Resistant Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Treated With Intravenously (IV) Infused Mirvetuximab Soravtansine
for
Advanced High-Grade Epithelial Ovarian Cancer,
Location: Worcester MA, Pittsburgh PA, Sarasota FL, Detroit MI,
Sponsor: AbbVie
Sex: Female
Age: 18+
Code: NCT06682988
Phase 2, Recruiting
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
for
Sinus Infection, Acute Sinusitis
Location: Hershey PA, Washington D.C. DC, Richmond VA, Madison WI,
Sponsor: Daniel Merenstein
Sex: All
Age: 18 - 70+
Code: NCT06076304
Recruiting
Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer
for
Non-Small Cell Lung Cancer
Location: Boston MA, Philadelphia PA, Arlington VA, Fairfield OH,
Sponsor: BicycleTx Limited
Sex: All
Age: 18+
Code: NCT06933329
Phase 2, Recruiting
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
for
Plasmablastic Lymphoma,
Location: New York NY, Philadelphia PA, Baltimore MD,
Sponsor: AIDS Malignancy Consortium
Sex: All
Age: 18+
Code: NCT04139304
Early Phase 1, Recruiting
A Global Study of the PETAL Consortium
for
T-Cell and NK-Cell Neoplasm
Location: Boston MA, Hackensack NJ, Philadelphia PA,
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: St. John's, Halifax, Bangor ME, Scarborough ME,